Health Catalyst, Inc. (HCAT) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Health Catalyst, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Health Catalyst, Inc. (HCAT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.54 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06

• Health Catalyst, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 6.95M shares, a 28.98% decline year-over-year.
• Health Catalyst, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 9.78M shares, a 29.58% decline year-over-year.
• Health Catalyst, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 13.89M shares, a 5.91% decline year-over-year.
• Health Catalyst, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 14.76M shares, a 0.23% increase year-over-year.
• Health Catalyst, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 7.47M shares, a 40.67% decline from fiscal 2024.
• Health Catalyst, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 12.60M shares, a 1.21% increase from fiscal 2023.
• Health Catalyst, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 12.45M shares, a 8.43% decline from fiscal 2022.
• Health Catalyst, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 13.59M shares, a 85.39% increase from fiscal 2021.